Three-year clinical outcomes of staged, ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease.

@article{Kim2014ThreeyearCO,
  title={Three-year clinical outcomes of staged, ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease.},
  author={Min Chul Kim and Myung Ho Jeong and Keun Ho Park and Doo Sun Sim and Nam Sik Yoon and Hyun Joo Yoon and Kye Hun Kim and Young Joon Hong and Hyung Wook Park and Ju Han Kim and Youngkeun Ahn and Jeong Gwan Cho and Jong Chun Park},
  journal={International journal of cardiology},
  year={2014},
  volume={176 2},
  pages={505-7}
}
patients with SLE developed cardiovascular events (event rate 3.2 per 100 person-years; non-fatal myocardial infarction, n=2; stroke, n=1; significant coronary artery disease, n=1). Importantly, compared to control individuals and patients without events, SLE patients with cardiovascular events had increased Ea (1.33 [1.25,1.49] versus 1.59 [1.40,1.93] versus 2.10 [1.59,2.98] mmHg/mL, respectively; Pb0.001) and Ea/Ees (0.49 [0.45,0.55] versus 0.55 [0.51,0.64] versus 0.59 [0.55,1.15… CONTINUE READING